A 65-year-old Nigerian doctor, Ndubuisi Joseph Okafor, was found by a federal jury in the U.S. District Court in connection with the illegal distribution of narcotic prescriptions in exchange for cash from his Northwest Washington, D.C. medical clinic.
The U.S. Department of Justice announced in a statement.
The judgment was made by U.S. Attorney Edward R. Martin (DEA special agent for the Washington Division of the Drug Enforcement Bureau).
The jury found Okafor conspiring to distribute controlled substances (outside medical practice), maintaining the premise involved in drugs, and 22 counts of illegal distribution of controlled substances (oxycodone and promethazine using codeine). U.S. District Judge John D. Bates plans to hold a sentencing hearing on June 20, 2025.
Okafor is the sole practitioner and owner of Okafor Medical Associates, a medical clinic in northwest Washington, D.C., between May 2021 and April 2023, according to court documents and evidence from the trial, between May 2021 and April 2023. Okafor is the sole practitioner and owner of Okafor Medical Associates, an internal medicine clinic in northwest Washington, D.C., based on court documents and evidence from the trial.
The U.S. Federal Bureau of Investigation (USAO) and the Federal Bureau of Investigation (USAO) and the FBI began investigating the illegal distribution of OKAFOR after receiving information from law enforcement agencies across the country about the prescriptions for the connection between OKAFOR and the local drug trafficking network.
Between February 18, 2022 and November 30, 2022, the FBI sent confidential resources and secret agents to Okafor’s medical practice for walk-in appointments. After a minimal check, Okafor opened everyone.
Further investigations show that Okafor is adopting a nationwide drug distribution program, so he will use false identities to prescribe opioids to a wide range of people, and Okafor knows they are transferring the drug.
Okafor’s behavior spans at least 45 states and has opened hundreds of thousands of units of oxycodone and promethazine units nationwide.
Okafor was convicted of being assigned to an undercover source, numerous uncharged accomplices, and merged by civilian joint venture patients, and was also convicted of conspiracy and maintaining the drug-related venue.
Evidence at the trial further showed that after the Washington, D.C. Health Commission notified Okafor that family members of the joint venture filed a complaint against him, he created a remodeled medical record for the joint venture to justify his prescription.
The investigation also resulted in the immediate suspension of the OKAFOR DEA registration number in September 2023 as it was considered a threat to public health and safety.
The case was investigated by the FBI’s Washington Office of the Field Office and the Office of the Inspector General of the District of Columbia Inspector General of the Medicaid Fraud Control Division, and was valuable assistance with valuable assistance from the Washington Division of the Drugs Executive Bureau.
The U.S. Attorney’s Office and the Department of Justice are very grateful to the North Carolina Police Department, Warsaw Police Department, New York, Police Department, North Dakota Criminal Investigation Bureau, Pennsylvania Police Department, Ohio Pharmacy Commission, and the offices in Ohio, Ohio, Ohio, Ohio, Sharif County for their extraordinary efforts, support, investigate, investigate and collaborate.
The case was prosecuted by Assistant U.S. Attorney Meredith Mayer-Dempsey, Trial Attorney Kathryn Furtado, Paralegal Rebecca Walton, Dillon Clark and Matthew McClarnon of the Justice Department’s fraud division.
The team also expressed deep appreciation to Michael Goodrich, chief travel analyst for the Department of Justice’s fraud division.
